Certara Reports First Quarter 2024 Financial Result Press Release Certara Reports First Quarter 2024 Financial Result Reiterates Full Year 2024 Financial Guidance PRINCETON, N.J.— May 7, 2024-- Certara, Inc. バイオシミュレーションのグローバルリーダーであるサターラ(Nasdaq:CERT) はCERT), a…Certara2024年5月7日
A Best Practice Guide to CDISC SDTM Mapping Guide A Best Practice Guide to CDISC SDTM Mapping Certara2024年5月7日
Dose Optimization Informed by PBPK Modeling: State-of-the Art and Future Publication PBPK モデリングに基づく用量最適化:最新動向と今後の展望 The article "Dose Optimization Informed by PBPK Modeling: State-of-the Art and Future" by Karen Rowland…Certara2024年5月6日
Prediction of Pediatric Pharmacokinetics for CYP3A4 Metabolized Drugs: Comparison of the Performance of Two Hepatic Ontogeny Within a Physiologically Based Pharmacokinetic Model Publication Prediction of Pediatric Pharmacokinetics for CYP3A4 Metabolized Drugs: Comparison of the Performance of Two Hepatic Ontogeny Within a Physiologically Based Pharmacokinetic Model The rapid growth in the use of pediatric physiologically based pharmacokinetic (PBPK) models, particularly for…Certara2024年5月6日
RAPS Sponsored Webcast: Regulatory & Tech Advances in Drug Safety Reporting On-Demand Webinar RAPS協賛Webcast: Regulatory & Tech Advances in Drug Safety Reporting Meeting the escalating global demand for new medications requires expediting regulatory submission development. Documenting drug…Certara2024年5月3日
Drug developers need curated clinical outcomes data to inform critical decisions On-Demand Webinar 創薬担当者にとって、重要な意思決定を支えるためには、精選された臨床アウトカムデータが不可欠です。 Certara2024年5月3日
Conducting Clinical Trials in the Parallel Virtual Universe Press Coverage Conducting Clinical Trials in the Parallel Virtual Universe Certara2024年5月3日
The Neuroplatform: Towards a Comprehensive Mechanistic QSP Model of Alzheimer’s Disease for Supporting Drug Discovery and Development On-Demand Webinar ニューロプラットフォーム:アルツハイマー病の包括的なメカニズムに基づくQSPモデルの構築による創薬・開発支援 With over 55 million people diagnosed worldwide, Alzheimer's disease presents a significant public health challenge,…Certara2024年4月29日
Multi-phase multi-layer mechanistic dermal absorption (MPML MechDermA) model to predict local and systemic exposure of drug products applied on skin Publication Multi-phase multi-layer mechanistic dermal absorption (MPML MechDermA) model to predict local and systemic exposure of drug products applied on skin Physiologically-based pharmacokinetic models combine knowledge about physiology, drug product properties, such as physicochemical parameters, absorption,…Certara2024年4月26日
Explore the World of Endogenous Biomarkers with Simcyp™! ビデオ Explore the World of Endogenous Biomarkers with Simcyp™! Endogenous biomarkers play a pivotal role in comprehending drug-body interactions, shaping drug development, and propelling…Certara2024年4月26日